$1.715
-0.044 (-2.56%)At close
Technical Sentiment
Overall Consensus
Technical Analysis Consensus
Moving Average Consensus
Zentalis Pharmaceuticals Inc (ZNTL) Moving Averages Convergence Divergence (MACD) indicator is -0.29, suggesting ZNTL is Strong sell.
Zentalis Pharmaceuticals Inc (ZNTL) 20-Day simple moving average is 2.15, while Zentalis Pharmaceuticals Inc (ZNTL) share price is $—, making it Sell.
Zentalis Pharmaceuticals Inc (ZNTL) 60-Day simple moving average is 2.95, while Zentalis Pharmaceuticals Inc (ZNTL) share price is $—, making it Sell.
Technical Analysis for ZNTL
AI Technical ZNTLAs of 2026-11-03, the technical board for Zentalis Pharmaceuticals Inc (ZNTL) reads strong sell: 2 indicators are flashing buy, 9 are indicating sell, and 2 are neutral. Price at $1.71 sits below every tracked moving average (5-day, 10-day, 20-day, 60-day and 200-day).
Momentum readings: RSI stands at 25.723, MACD stands at -0.286 (Sell), Stochastic %K stands at 6.135 (Buy), Stochastic %D stands at 5.897 and CCI stands at -139.047 (Buy).
ZNTL trades below the 60-day SMA (2.95) and below the 200-day SMA (3.43). Immediate resistance sits at Classic R1 2.35, then R2 2.77. Support sits at Classic S1 1.57, then S2 1.21.
Zentalis Pharmaceuticals Inc (ZNTL) Support & Resistance Level
Zentalis Pharmaceuticals Inc (ZNTL) Technical Indicators
2026-11-03
| Name | Value |
|---|---|
| RSI_14 | 25.723 |
| STOCHk_14_3_3 | 6.135 |
| STOCHd_14_3_3 | 5.897 |
| CCI_20 | -139.047 |
| AO_5_34 | -0.568 |
| MOM_10 | -0.700 |
| MACD_12_26_9 | -0.286 |
Zentalis Pharmaceuticals Inc (ZNTL) Relative Strength Index (RSI_14) is 25.723, creating a Buy signal.
Zentalis Pharmaceuticals Inc (ZNTL) Stochastic %K is 6.135, creating a Buy signal.
Zentalis Pharmaceuticals Inc (ZNTL) Stochastic %D is 5.897, creating a Buy signal.
Zentalis Pharmaceuticals Inc (ZNTL) CCI_20 is -139.047, creating a Buy signal.
Zentalis Pharmaceuticals Inc (ZNTL) Awesome Oscillator (AO) is -0.568, creating a Sell signal.
Zentalis Pharmaceuticals Inc (ZNTL) Momentum (MOM) is -0.700, creating a Sell signal.
Zentalis Pharmaceuticals Inc (ZNTL) Moving Average Convergence Divergence (MACD) is -0.286, creating a Sell signal.
Zentalis Pharmaceuticals Inc (ZNTL) Moving Average
2026-11-03
| Period | Simple | Signal |
|---|---|---|
| MA_5 | 1.812 | Sell |
| MA_10 | 1.937 | Sell |
| MA_20 | 2.154 | Sell |
| MA_60 | 2.953 | Sell |
| MA_200 | 3.430 | Sell |
| MA_250 | 3.090 | Sell |
Zentalis Pharmaceuticals Inc (ZNTL) 5-Day simple moving average is 1.812, while Zentalis Pharmaceuticals Inc (ZNTL) share price is $, making it a Sell.
Zentalis Pharmaceuticals Inc (ZNTL) 10-Day simple moving average is 1.937, while Zentalis Pharmaceuticals Inc (ZNTL) share price is $, making it a Sell.
Zentalis Pharmaceuticals Inc (ZNTL) 20-Day simple moving average is 2.154, while Zentalis Pharmaceuticals Inc (ZNTL) share price is $, making it a Sell.
Zentalis Pharmaceuticals Inc (ZNTL) 60-Day simple moving average is 2.953, while Zentalis Pharmaceuticals Inc (ZNTL) share price is $, making it a Sell.
Zentalis Pharmaceuticals Inc (ZNTL) 200-Day simple moving average is 3.430, while Zentalis Pharmaceuticals Inc (ZNTL) share price is $, making it a Sell.
Zentalis Pharmaceuticals Inc (ZNTL) 250-Day simple moving average is 3.090, while Zentalis Pharmaceuticals Inc (ZNTL) share price is $, making it a Sell.
Related articles
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.